This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES: Oligonucleotide & Peptide Therapeutics Content Hub
24/7 Access
Digital & In-Person
Menu

Ben Andrews, Ph.D.
Scientific Investigator at GlaxoSmithKline
Speaker

Profile

Studied Biochemistry/Chemistry at University followed by a PhD and Postdoc in Synthetic Organic Chemistry. Worked in the API Chemistry department at GlaxoSmithKline, Stevenage UK for 7 years on small molecule process development, and 6 years on oligonucleotide process development.

Agenda Sessions

  • Oligonucleotide Green Chemistry: A Contradiction in Terms?

    On Demand - Premium Only